Author:
Brunner Stefanie,Müller Dolores T.,Eckhoff Jennifer A.,Reisewitz Alissa,Schiffmann Lars M.,Schröder Wolfgang,Schmidt Thomas,Bruns Christiane J.,Fuchs Hans F.
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Shapiro J, van Lanschot JJB, Hulshof MCCM, van Hagen P, van Berge Henegouwen MI, Wijnhoven BPL et al (2015) Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol 16(9):1090–1098
2. Porschen R, Fischbach W, Gockel I, Hollerbach S, Hölscher A, Jansen PL et al (2022) S3-Leitlinie – Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des ösophagus. Z Gastroenterol 57(3):336–418
3. Schmidt T, Babic B, Bruns CJ, Fuchs HF (2021) Surgical treatment of esophageal cancer-new technologies, modern concepts. Chirurg 92(12):1100–1106
4. Babic B, Fuchs HF, Bruns CJ (2020) Neoadjuvant chemoradiotherapy or chemotherapy for locally advanced esophageal cancer? Chirurg 91(5):379–383
5. Leal Ghezzi T, Campos Corleta O (2016) 30 years of robotic surgery. World J Surg 40(10):2550–2557